Available IPD datapackage for study 'Phase II Study to Evaluate the Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg in Postmenopausal Women With ER +ve Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy'

This study will assess the relationship between fulvestrant dose and efficacy in postmenopausal women with oestrogen receptor positive advanced breast cancer.

本研究旨在评估氟维司群（fulvestrant）剂量与疗效之间的关联，研究对象为雌激素受体阳性（oestrogen receptor positive）的绝经后晚期乳腺癌女性患者。